Trials / Completed
CompletedNCT01269905
Choice of Valve Substitute in the Era of Oral Anticoagulation Self-Management
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- —
- Sponsor
- Johann Wolfgang Goethe University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The optimal valve substitute for patients between 60-70 years is controversial. We compared anticoagulation-related adverse events (ARAE) in patients receiving mechanical heart valve replacement (MHVR) on INR self-management vs. stentless bioprosthesis, to assess whether the risk of structural valve deterioration (SVD) is still out-weighted by the benefit of not requiring permanent anticoagulation.
Conditions
Timeline
- First posted
- 2011-01-04
- Last updated
- 2011-01-04
Source: ClinicalTrials.gov record NCT01269905. Inclusion in this directory is not an endorsement.